I-Curantil ibhekisela emithini yemithi eyenza i-antiplatelet (antithrombotic) kanye ne-angioprotective (action-strengthening-action). Ngaphezu kwalokho, lesi sidakamizwa sithuthukisa ukukhulelwa komzimba .
Isenzo sezokwelapha kanye nendlela yokukhululwa kwezidakamizwa iKurantil
Ingxenye enkulu esebenzayo yezidakamizwa i-Kurantil - dipyridamole. Into esebenzayo inemiphumela elandelayo yemithi emzimbeni:
- ivula isibani semikhumbi ye-coronary;
- kwandisa ijubane lokugeleza kwegazi;
- ivuselela ukunikezwa kwe-myocardium nge-oxygen;
- kushukumisa ukuhlanganiswa kwe-interferon;
- ivimbela ukuhlanganiswa kwamaplatelets egazini.
Ukulungiselela imithi Kurantil iyatholakala ngendlela:
- amaphilisi ane-25, 50, 75 noma 100 mg we-dipyridamole;
- ama-dragee aqukethe ama-25 no-75 mg wezithako ezisebenzayo;
- Isixazululo se-0.5% ku-ampoules.
Izinkomba nokuphikisana nokusetshenziswa kwesidakamizwa Curantil
Izimpawu zokusetshenziswa kwemithi yokwelapha i-Curantil ngokwemiyalo yilezi:
- ukwephula ukujikeleza kwe-cerebral ngokusho kohlobo lwe-ischemia;
- encephalopathy ye-discirculatory;
- ukucindezeleka okukhulu;
- ukuqeda ukuphela komzimba ;
- isandulela-infarction kanye post-infarction uthi;
- ukuphefumula kwamathambo wezitsha zenhliziyo;
- ukuvimbela i-thrombosis ne-thromboembolism, kufaka phakathi ngemuva kwama-valve heart valve;
- noma yikuphi ukuphulwa kwegazi lokukhipha i-microcirculation;
- ukwandisa igciwane lesandulela-ngculazi ezifozini zomkhuhlane kanye ne-ARVI.
Ochwepheshe futhi bacabangela ukungakwazi kahle kwamapulangwe ngesikhathi sokukhulelwa njengendlela yokusetshenziswa kwezidakamizwa ze-Curantil. Uma isongo esivela esimweni sidlula ingozi yokuthatha imithi, inikwe umama ozayo.
Ukungahambisani nokusetshenziswa kwezidakamizwa i-Kurantil kunezifo ezinzima ezihlobene nokuphulwa kwe-microcirculation yegazi, izimo ezingaguquki nezokukhokha. Isidakamizwa asikalelwe izifo ezilandelayo:
- i-myocardial acute noma i-brain infarction;
- i-angina enzima;
- hypotension, i-syncope;
- ukuphazamiseka okweqile nokwehluleka kwe-hepatic;
- ukuhluleka kwenhliziyo esigabeni sokuqedela;
- i-dystonia yemifino yemvelo;
- ukuvinjelwa kwesistimu ye-bronchopulmonary;
- ukuthambekela kokuphuma kwamanzi, kuhlanganise nokutholakala kwesilonda se-peptic;
- i-arrhythmias yenhliziyo;
- ukucindezela izigaba ezidakamizwa.
Kuyinto engathandeki ukusebenzisa i-Curantil ekwelapheni izingane ezingaphansi kweminyaka engu-12 ubudala.
Indlela yokusebenzisa izidakamizwa ze-Curantil
Ngomlomo, kutuswa ukuthatha i-Churantil ngaphambi kokudla noma amahora amabili ngemuva kokudla. Amathebulethi (ama-dragees) kufanele ahliswe phansi ngamanzi amaningi noma ubisi (okugcina kunciphisa izidakamizwa zesifo sohudo). Odokotela bayeluleka ukuthi bangasebenzisi itiye nekhofi ekwelapheni, ngoba lezi ziphuzo zinciphisa isenzo se-dipyridamole. Kumele futhi uqaphele ukuthi i-Curantil ikhulisa umphumela wezidakamizwa ezidambisayo kanye nezidakamizwa ezichitha igazi.
Umthamo wesidakamizwa uncike ekutheni izinga lokuthuthukiswa kwesifo kanye nezici zomuntu ngamunye. I-Courantil esilinganisweni se-75 mg iqukethe izinto eziningi ezisebenzayo. Izinkomba zokusetshenziswa kwezidakamizwa i-Curantil 75, njengomthetho, zihluleka inhliziyo kanye nokuphazamiseka kwe-cerebral disorders. Ngezifo zalolu hlobo, imvamisa yemithi ingama-3-6 izikhathi ngosuku. Njenge-antiggregant agent, i-Curantil 75 inqunywe umthamo weziphilisi ezi-3-9 ngosuku.
Ukuze kuvikelwe izifo ezibangelwa amagciwane, i-Kurantil ivame ukusetshenziselwa umthamo we-25. Lesi sidakamizwa sinconywa ngesikhathi izifo zengculazi ziphuza kabili ngosuku ngamaphilisi amabili ngesikhathi samukelwa.